InspireMD (NSPR) FCF Margin Growth (1y) (2011 - 2025)
InspireMD (NSPR) FCF Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -473.00 |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn | 5,289.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,289.00 |
| Sep 30, 2025 | -1,704.00 |
| Jun 30, 2025 | -22,338.00 |
| Mar 31, 2025 | -25,045.00 |
| Dec 31, 2024 | -11,288.00 |
| Sep 30, 2024 | -7,217.00 |
| Jun 30, 2024 | -7,332.00 |
| Mar 31, 2024 | 4,388.00 |
| Dec 31, 2023 | 7,126.00 |
| Sep 30, 2023 | 10,646.00 |
| Jun 30, 2023 | 622.00 |
| Mar 31, 2023 | -3,935.00 |
| Dec 31, 2022 | -10,269.00 |
| Sep 30, 2022 | 2,875.00 |
| Jun 30, 2022 | 3,817.00 |
| Mar 31, 2022 | 1,193.00 |
| Dec 31, 2021 | 121,367.00 |
| Sep 30, 2021 | -9,060.00 |
| Jun 30, 2021 | 22,505.00 |
| Mar 31, 2021 | -13,685.00 |